Filing Manager
PERCEPTIVE ADVISORS LLC
Reporting Manager
Perceptive Advisors LLC
Symbol
TRAW
Shares outstanding
8,877,748 shares
Disclosed Ownership
886,887 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:00:03 UTC
Date of event
30 Sep 2025
Previous filing
15 May 2025

Sponsored

Quoteable Key Fact

"PERCEPTIVE ADVISORS LLC disclosed 10% ownership in Traws Pharma, Inc. Common Stock, par value $0.01 per share (TRAW) on 30 Sep 2025."

Quick Takeaways

  • PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G/A for Traws Pharma, Inc. Common Stock, par value $0.01 per share (TRAW).
  • Disclosed ownership: 10%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 15 May 2025.
  • Current filing was accepted on 14 Nov 2025, 16:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Perceptive Advisors LLC 10% 886,887 0 886,887 /s/ Joseph Edelman Joseph Edelman, Managing Member
Joseph Edelman 10% 886,887 0 886,887 /s/ Joseph Edelman Joseph Edelman
Perceptive Life Sciences Master Fund, Ltd. 10% 886,887 0 886,887 /s/ Joseph Edelman Joseph Edelman, Managing Member